Mount Yale Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.8M Buy
42,234
+21,749
+106% +$22M 0.9% 17
2025
Q4
$22M Buy
20,485
+2,296
+13% +$2.2M 1.06% 17
2025
Q3
$13.9M Buy
18,189
+14,797
+436% +$11M 0.97% 20
2025
Q2
$2.64M Sell
3,392
-933
-22% -$725K 0.21% 99
2025
Q1
$3.57M Buy
4,325
+295
+7% +$245K 0.31% 65
2024
Q4
$3.11M Hold
4,030
0.25% 80
2024
Q3
$3.57M Sell
4,030
-189
-4% -$170K 0.34% 67
2024
Q2
$3.82M Sell
4,219
-189
-4% -$151K 0.3% 69
2024
Q1
$3.43M Buy
4,408
+278
+7% +$198K 0.26% 81
2023
Q4
$2.41M Buy
4,130
+649
+19% +$379K 0.23% 103
2023
Q3
$1.87M Sell
3,481
-165
-5% -$85K 0.2% 114
2023
Q2
$1.71M Sell
3,646
-42
-1% -$17.6K 0.18% 123
2023
Q1
$1.27M Sell
3,688
-318
-8% -$107K 0.14% 150
2022
Q4
$1.47M Buy
4,006
+62
+2% +$22K 0.17% 141
2022
Q3
$1.27M Buy
3,944
+58
+1% +$18.4K 0.17% 129
2022
Q2
$1.26M Sell
3,886
-472
-11% -$142K 0.16% 145
2022
Q1
$1.25M Sell
4,358
-577
-12% -$148K 0.14% 166
2021
Q4
$1.36M Buy
4,935
+2,228
+82% +$565K 0.14% 154
2021
Q3
$625K Buy
+2,707
New +$668K 0.07% 244
2018
Q4
Sell
-176
Closed -$19K 561
2018
Q3
$19K Sell
176
-84,317
-100% -$8.43M ﹤0.01% 791
2018
Q2
$7.21M Buy
84,493
+3,732
+5% +$307K 1.36% 14
2018
Q1
$6.25M Buy
+80,761
New +$6.5M 1.34% 19

Other funds holding LLY

Mount Yale Investment Advisors's LLY Position: Q1 2026 in Review

Mount Yale Investment Advisors increased its Eli Lilly (LLY) stake by 106% in Q1 2026, buying an estimated $22M and bringing the position to 42,234 shares worth $38.8M. The position accounts for 0.9% of the portfolio, ranked #17.

Mount Yale Investment Advisors first reported a position in LLY in Q1 2018 and has held it in 22 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mount Yale Investment Advisors held 42,234 shares of Eli Lilly worth $38.8M as of Q1 2026.
  • Mount Yale Investment Advisors bought 21,749 Eli Lilly shares in Q1 2026, an estimated $22M.
  • Eli Lilly made up 0.9% of Mount Yale Investment Advisors's portfolio in Q1 2026, its #17 holding.
  • Mount Yale Investment Advisors first reported a position in Eli Lilly in Q1 2018 and has held it in 22 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.